Effect Of Extract Breadfruit Leaf (Artocarpus altilis (Park.) Fosberg) Toward Tumor Necrosis Factor (TNF- α) In Obese Rat (Rattu norvegicus) With Insulin Resistance

Wahyudin Wahyudin, Hasanuddin Nuru, Hendra Stevani, Salmah Arafah


Tumor necrosis factor-α (TNF-α) contributed to the insulin resistance which leads to type 2 diabetes. The A. altilis plant has traditionally been used by the Indonesian people to treat diabetes mellitus. The purpose of this study was to determine the parameter of TNF-α level in obese mice (Rattus norvegicus). This study was used experimental laboratory with Randomized Controlled Trial (RCT) design. It’s divided into 5 groups, and each group consisted of 5 rats that have been given a 45% fat (open source) high fat diet for fattening itself. Measurement of body weight to assess obesity and examination of fasting blood sugar (GDP) were used of DR glucose test kits. Group I was negative control, group II as positive control using metformin HCl, group III using A. altilis 5%, group IV A. altilis with 10% and group V A. altilis with 15%. Treatment was carried out for 14 days in each group and TNF-α levels was assessed with ELISA test. Nonparametric test was used to see the differences between each groups with a 95% confidence level. There was a significant effect of A. altilis with 10% extract toward TNF-α levels, where the value of p = 0.018. While the administration of extracts of 5% and 15% did not show a significant effect. The administration of 10% A. altilis extract showed a significant decrease of TNF-α levels in obese mice who had hyperglycemia.

Keywords: A. altilis, obesitas, TNF-α, insulin resistance

Full Text:



Vorst MMJvd. 2015. Population-Based Studies on the Epidemiology of Insulin Resistance in Children. Journal of diabetes research. 2015;2015:9.

Aeslan N, Erdur B, Aydin A. 2010. Hormones and Cytokines in Childhood Obesity. Indian pediatrics.

Akash MSH, Rehman K, Liaqat A. 2018. Tumor Necrosis Factor-Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus. Journal of cellular biochemistry. 2018;119(1):105-10.

Chan K. 2003. Some aspects of toxic contaminants in herbal medicines. Chemosphere. 2003;52(9):1361-71.

Chen L, Chen R, HuaWang, Liang F. 2015. Mechanisms Linking Inflammation to Insulin Resistance. International journal of endocrinology. 2015;2015:9.

Crescenzo R, Bianco F, Mazzoli A, Giacco A, Liverini G, Iossa S. 2015. Mitochondrial efficiency, and insulin resistance. Frontiers in physiology. 2015;5(512):5.

Dalziel B, Gosby AK, Richman RM, Bryson JM, Caterson ID. 2002. Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity. Obesity research. 2002;10(5):401-7.

Evia-Viscarra ML, Rodea-Montero ER, Apolinar-Jimenez E, Munoz-Noriega N, Garcia-Morales LM, Leanos-Perez C, et al. 2012. The effects of metformin on inflammatory mediators in obese adolescents with insulin resistance: controlled randomized clinical trial. Journal of pediatric endocrinology & metabolism : JPEM. 2012;25(1-2):41-9.

Gerritsen ME, Carley WW, Ranges GE, Shen CP, Phan SA, Ligon GF, et al. 1995. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. The American journal of pathology. 1995;147(2):278-92.

Halle M, Berg A, Northoff H, Keul J. 1998. Importance of TNF-alpha and leptin in obesity and insulin resistance: a hypothesis on the impact of physical exercise. Exercise immunology review. 1998;4:77-94.

Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996;271(5249):665-8.

Hotamisligil GS, Shargill NS, Spiegelman BM. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259(5091):87-91.

Hotamisligil GS. 1999. The role of TNF alpha and TNF receptors in obesity and insulin resistance. Journal of internal medicine. 1999;245(6):621-5.

Indrowati M, Pratiwi R, Rumiyati, Astuti P. 2017. Levels of Blood Glucose and Insulin Expression of Beta-cells in Streptozotocin-induced Diabetic Rats Treated with Ethanolic Extract of Artocarpus altilis Leaves and GABA. Pakistan journal of biological sciences : PJBS. 2017;20(1):28-35.

Kahn SE, Hull RL, Utzschneider KM. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840-6.

Lee JM, Okumura MJ, Davis MM. 2006. Prevalence and Determinants of Insulin Resistance among US Adolescents. Diabetes care. 2006;29(11):2427–32.

Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, Diehl AM. 2000. Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nature medicine. 2000;6(9):998-1003.

McCormack JP, Allan GM, Virani AS. 2011. Is bigger better? An argument for very low starting doses. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2011;183(1):65-9.

Nguyen MT, Nguyen NT, Awale S. Prenylated. 2015. Dihydrochalcones from Artocarpus altilis as Antiausterity Agents. The Enzymes. 2015;37:95-110.

Nuru H, Piaseu N, Phuphaibul R, Suthutvoravut U. 2017. Predictors of Insulin Resistance in Indonesian Adolescents with Obesity. Pacific Rim International Journal Nurs. 2017;21(4):280-90.

Ren T, He J, Jiang H, Zu L, Pu S, Guo X, et al. 2006. Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-alpha or isoproterenol. Journal of molecular endocrinology. 2006;37(1):175-83.

Romualdoa MCdS, Nobregab FJd, Escrivao MAMS. 2014. Insulin resistance in obese children and adolescents. Journal de Pediatria. 2014;90(9):600-7.

Sikarwar MS, Hui BJ, Subramaniam K, Valeisamy BD, Yean LK, Balaji K. 2014. Antioxidant activity of Artocarpus altilis (Parkinson) Fosberg leaves. Free Radicals and Antioxidants. 2014;4(2).

Sikarwar MS, Hui BJ, Subramaniam K, Valeisamy BD, Yean LK, Balaji K. A. 2014. Review on Artocarpus altilis (Parkinson) Fosberg (breadfruit). Journal of Applied Pharmaceutical Science 2014;4(08):091-7.

Wachtel-Galor S, Benzie IFF. 2011. Herbal Medicine: Biomolecular and Clinical Aspects. An Introduction to Its History, Usage, Regulation, Current Trends, and Research Needs.

DOI: https://doi.org/10.32382/mf.v18i1.2744


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Kontak Editor

Hendra Stevani

Jurusan Farmasi Poltekkes kemenkes Makassar

email : hendra@poltekkes-mks.ac.id

View My Stats

Flag Counter

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.